Cleveland BioLabs
CBLI
#9790
Rank
C$67.61 M
Marketcap
C$4.37
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Cleveland BioLabs (CBLI)

Last known market cap: C$67.61 Million

As of December 2025 Cleveland BioLabs has a market cap of C$67.61 Million. This makes Cleveland BioLabs the world's 9790th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cleveland BioLabs from 2006 to 2022

End of year Market Cap

Year Marketcap Change
2022C$66.58 M6.47%
2021C$62.53 M9.21%
2020C$57.25 M544.57%
2019C$8.88 M-42.85%
2018C$15.54 M-72.67%
2017C$56.86 M171.23%
2016C$20.96 M-60.58%
2015C$53.19 M181.36%
2014C$18.9 M-66.4%
2013C$56.27 M-4.88%
2012C$59.15 M-42.74%
2011C$0.10 B-50.57%
2010C$0.20 B197.03%
2009C$70.36 M98.38%
2008C$35.46 M-68.68%
2007C$0.11 B63.18%
2006C$69.39 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
C$28.8 M-57.40%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
C$1.43 B 2,019.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$241.89 B 357,668.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$357.00 B 527,930.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
C$150.21 B 222,069.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$161.91 B 239,375.34%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
C$135.40 B 200,168.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
C$17.09 M-74.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$1.286 T 1,903,212.77%๐Ÿ‡บ๐Ÿ‡ธ USA